Finance

The vocal activist investor has a pretty concentrated portfolio.

These companies are both expanding quickly in AI, but one is trading at a far better value.

It’s not a bargain buy, but it is a business gearing up for a boom.

Several dynamics in the company’s business are causes for concern.

This pair of fintech stocks is being underestimated by the market.

Learn what makes this Vanguard ETF special.

Altimmune has a modest market cap but an incredibly promising GLP-1 drug.

These companies have long track records of paying durable dividends.

It’s time to change the math behind your relationship with money.

These companies have fundamental advantages that will make rewarding investments for years to come.

Although a tax refund isn’t a windfall per se, it’s important to put that money to good use.

Meta Platforms and Alphabet recently announced products to challenge Nvidia’s position.

ASML reported quarterly earnings results that provided critical information to investors.

AI is one of the many drivers powering demand for natural gas over the coming years.

There are several reasons you might want to sell Altria, but there’s one very big reason why you might want to buy and hold.

Investors can identify favorable qualities in both of these innovative businesses.

Investors should pay more attention to this little digital bank.

This company has been around for decades, but the recent AI boom has supercharged growth.

Investing in start-ups has wide appeal, and this fund allows you to mimic the moves of high-profile billionaires.

A middle-ground claims approach is likely resulting in a lot of Social Security income being left on the table.